Relmada Therapeutics to Report Second Quarter 2026 Financial Results on Thursday, August 6, 2026

Go back to Relmada Therapeutics to Report Second Quarter 2026 Financial Results on Thursday, August 6, 2026
(NASDAQ: RLMD) Delayed: 4.43 +0.06 (1.37%)
Previous Close $4.37    52 Week High $4.10 
Open $4.35    52 Week Low $0.87 
Day High $4.44    P/E N/A 
Day Low $4.32    EPS $0.00 
Volume 675,556